Isotopically Labeled Compounds
Cambridge Isotope Laboratories Cyfluthrin, (mix of stereoisomers) (phenoxy-13C6, 99%) 100 ug/mL in Nonane | 68359-37-5 | MFCD00078636 | 1.2 mL
Cyfluthrin, (mix of stereoisomers) (phenoxy-13C6, 99%) 100 ug/mL in Nonane | Putity: 98% | MW: 440.2 | 68359-37-5 | MFCD00078636 | 1.2 mL
Cambridge Isotope Laboratories Fenvalerate (D6, 98%) 100ug/mL in Nonane | 51630-58-1 | MFCD00055324 | 1.2 mL
Fenvalerate (D6, 98%) 100ug/mL in Nonane | Putity: 98% | MW: 425.94 | 51630-58-1 | MFCD00055324 | 1.2 mL
Medchemexpress LLC Succinimide-15N | 32807-36-6 | 99.0% | 100.08 | 5 MG
Succinimide-15N is a 15N labeled succinimide that rapidly hydrolyzes into aspartic acid during reduction/alkylation processes. This compound is utilized in the development of antiepileptic agents. It can also serve as a tracer and as an internal standard for quantitative analysis by techniques such as NMR, GC-MS, or LC-MS.
- Can be used as a tracer
- Functions as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Supports the development of antiepileptic agents
- Incorporates stable heavy isotopes into drug molecules for quantification during drug development
Sigma Aldrich Fine Chemicals Biosciences L-Cysteine-13C3,15N >=99 atom %, >=98% (CP) | 202406-97-1 | MFCD01073449 | 100MG
L-Cysteine-13C3,15N >=99 atom %, >=98% (CP) | Purity: >=98% (CP) | Mol Wt: 125.13 | 202406-97-1 | MFCD01073449 | 100MG
Sigma Aldrich Fine Chemicals Biosciences Acrylamide-13C3 99 atom % 13C, 98% (CP) | 287399-26-2 | MFCD00143545 | 20MG
Acrylamide-13C3 99 atom % 13C, 98% (CP) | Purity: 98% (CP) | Mol Wt: 74.06 | 287399-26-2 | MFCD00143545 | 20MG
Sigma Aldrich Fine Chemicals Biosciences Eicosanoic-d39 Acid 98 atom % D, 97% (CP) | 39756-32-6 | MFCD00143629 | 500MG
Eicosanoic-d39 Acid 98 atom % D, 97% (CP) | Purity: 97% (CP) | Mol Wt: 351.77 | 39756-32-6 | MFCD00143629 | 500MG
Sigma Aldrich Fine Chemicals Biosciences Acrylamide-13C3 | 287399-26-2 | MFCD00143545 | 50mg
Acrylamide-13C3 | Mol Wt: 74.06 | 287399-26-2 | MFCD00143545 | 50mg
Cayman Chemical DeoxycholIc AcId-d4 10mg
An internal standard for the quantification of DCA by GC- or LC-MS
Medchemexpress LLC 2-mercaptoethanol-d6 | 203645-37-8 | 99.7% | 84.17 | C2D6OS | 25mg
2-Mercaptoethanol-d6 is deuterium labeled 2-Mercaptoethanol[1]
Sigma Aldrich Fine Chemicals Biosciences Acrylonitrile-d3 98 atom % D, >=99% (CP), contains hydroquinone as stabilizer | 53807-26-4 | MFCD00143554 | 1G
Acrylonitrile-d3 98 atom % D, >=99% (CP), contains hydroquinone as stabilizer | Purity: >=99% (CP) | Mol Wt: 56.08 | 53807-26-4 | MFCD00143554 | 1G
Medchemexpress LLC Lercanidipine-d3 hydrochloride | 1189954-18-4 | 98.14% | 1 MG
Lercanidipine-d3 hydrochloride is the deuterium-labeled form of Lercanidipine, a lipophilic third-generation dihydropyridine-calcium channel blocker (DHP-CCB). It offers long-lasting antihypertensive action and reno-protective effects. Stable heavy isotopes of hydrogen, carbon, and other elements are incorporated into drug molecules primarily as tracers for quantitation during drug development. Deuteration can impact the pharmacokinetic and metabolic profiles of drugs.
- Functions as a tracer
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
Medchemexpress LLC Atorvastatin-d5 (sodium) | 222412-87-5 | 96.95% | 1 MG
Atorvastatin-d5 (sodium) is a deuterium-labeled Atorvastatin sodium. It acts as an orally active HMG-CoA reductase inhibitor, effectively decreasing blood lipids. This compound also inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM respectively. Deuteration, the incorporation of stable heavy isotopes, can influence the pharmacokinetic and metabolic profiles of drugs.
- Can be used as a tracer
- Serves as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Effectively decreases blood lipids
- Inhibits human SV-SMC proliferation and invasion
Cayman Chemical UrsodeoxycholIc AcId-d4 500ug
An internal standard for the quantification of ursodeoxycholic acid by GC- or LC-MS
Medchemexpress LLC Cabozantinib-d6 | 1802168-46-2 | 98.1% | 1 MG
Cabozantinib-d6 is a deuterium-labeled derivative of Cabozantinib, a potent inhibitor targeting multiple receptor tyrosine kinases (RTKs) including VEGFR2, c-Met, Kit, Axl, and Flt3. This compound is designed for research applications, serving as a valuable tracer or internal standard for precise quantitative analysis methods such as NMR, GC-MS, and LC-MS.
- Deuterium-labeled compound
- Potent inhibitor of multiple receptor tyrosine kinases
- Inhibits VEGFR2, c-Met, Kit, Axl, and Flt3
- Useful as a tracer in research
- Functions as an internal standard for quantitative analysis
- Compatible with NMR, GC-MS, and LC-MS techniques
- Intended for research use only